.

Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Identify first generic entrants
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Queensland Health
Boehringer Ingelheim
AstraZeneca
Merck
Harvard Business School
Federal Trade Commission
Chinese Patent Office
Daiichi Sankyo
Citi
Fish and Richardson

Generated: June 24, 2017

DrugPatentWatch Database Preview

EFFEXOR Drug Profile

« Back to Dashboard

Which patents cover Effexor, and what generic Effexor alternatives are available?

Effexor is a drug marketed by Wyeth Pharms Inc and is included in two NDAs. There are three patents protecting this drug and two Paragraph IV challenges.

The generic ingredient in EFFEXOR is venlafaxine hydrochloride. There are seventy drug master file entries for this compound. Seventy-three suppliers are listed for this compound. Additional details are available on the venlafaxine hydrochloride profile page.

Summary for Tradename: EFFEXOR

Patents:0
Applicants:1
NDAs:2
Bulk Api Vendors: see list110
Clinical Trials: see list56
Patent Applications: see list1,549
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:EFFEXOR at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Wyeth Pharms Inc
EFFEXOR
venlafaxine hydrochloride
TABLET;ORAL020151-001Dec 28, 1993DISCNYesNo► Subscribe► Subscribe
Wyeth Pharms Inc
EFFEXOR XR
venlafaxine hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL020699-004Oct 20, 1997ABRXYesYes6,419,958*PED► SubscribeY► Subscribe
Wyeth Pharms Inc
EFFEXOR XR
venlafaxine hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL020699-001Oct 20, 1997ABRXYesNo6,274,171*PED► SubscribeY► Subscribe
Wyeth Pharms Inc
EFFEXOR
venlafaxine hydrochloride
TABLET;ORAL020151-003Dec 28, 1993DISCNYesNo► Subscribe► Subscribe
Wyeth Pharms Inc
EFFEXOR XR
venlafaxine hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL020699-002Oct 20, 1997ABRXYesNo6,419,958*PED► SubscribeY► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: EFFEXOR

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Wyeth Pharms Inc
EFFEXOR
venlafaxine hydrochloride
TABLET;ORAL020151-002Dec 28, 19934,535,186*PED► Subscribe
Wyeth Pharms Inc
EFFEXOR
venlafaxine hydrochloride
TABLET;ORAL020151-004Dec 28, 19936,274,171► Subscribe
Wyeth Pharms Inc
EFFEXOR
venlafaxine hydrochloride
TABLET;ORAL020151-002Dec 28, 19936,274,171► Subscribe
Wyeth Pharms Inc
EFFEXOR
venlafaxine hydrochloride
TABLET;ORAL020151-006Dec 28, 19934,535,186*PED► Subscribe
Wyeth Pharms Inc
EFFEXOR
venlafaxine hydrochloride
TABLET;ORAL020151-001Dec 28, 19934,535,186*PED► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for: EFFEXOR

Drugname Dosage Strength RLD Submissiondate
venlafaxine hydrochlorideExtended-release Tablets37.5 mg, 75 mg and 150 mgEffexor XR5/3/2007
venlafaxine hydrochlorideTablets25 mg, 37.5 mg, 50 mg, 75 mg and 100 mgEffexor11/3/2005
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

McKesson
Mallinckrodt
Boehringer Ingelheim
Dow
Johnson and Johnson
Covington
Fuji
Novartis
Farmers Insurance
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot